Salix Pharmaceuticals Ltd. (SLXP) Earnings
|
Expand Research on SLXP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +251.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/15  |
 |
Q414 | $2.61 | -$0.29 | +$2.90 | $13M | $187.97M | N/A |  | | Details |
| 11/6/14 |
|
Q314 | $1.53 | $1.56 | -$0.03 | $354.7M | $394M | N/A | | | Details |
| 8/7/14 |
|
Q214 | $1.59 | $1.69 | -$0.10 | $382M | $397.06M | N/A | | | Details |
| 5/8/14 |
|
Q114 | $1.05 | $0.91 | +$0.14 | $384M | $372.91M | N/A | | | Details |
| 2/27/14 |
|
Q413 | $1.06 | $0.93 | +$0.13 | $257.6M | $247.29M | N/A | | | Details |
| 11/7/13 |
|
Q313 | $0.89 | $0.86 | +$0.03 | $238.18M | $239.7M | N/A | | | Details |
| 8/8/13 |
|
Q213 | $0.87 | $0.81 | +$0.06 | $235.4M | $226.34M | N/A | | | Details |
| 5/9/13 |
|
Q113 | $0.63 | $0.68 | -$0.05 | $202.6M | $205.94M | N/A | | | Details |
